Rivabazumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5827
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Rivabazumab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
PcrV protein type III secretion system
Concentration
5mg/ml
Isotype
Fab' - G1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
PcrV is the tip protein of the Pseudomonas aeruginosa type III secretion system, a virulence structure that injects toxins into host cells and a long-standing target for anti-infective research. This research-grade reagent is an unconjugated, non-therapeutic analog of rivabazumab, supplied as a recombinant Fab' fragment directed against PcrV. Intended strictly for research use only (RUO), it is produced to in vivo standards in a low-endotoxin format and offered in scalable milligram to gram quantities for heavy-usage and high-throughput laboratories. It supports preclinical work spanning functional assays, neutralization studies of secretion-system activity, and in vivo infection models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Rivabazumab Biosimilar - Research Grade
Your Rating
Back to Top